reported that LSD1 deletion could reduce PD-L1 accumulation in exosomes and inhibit PD-L1 transport to other cancer cells via exosomes, thereby enhancing the activity of T cells and restoring the ability of T cells to kill tumor cells in TME, thus overcoming immunosuppression (88). The gene discussed is CD274; the disease is cancer.